论文部分内容阅读
1989～1993年,我院共收治预激综合征(预激)伴房颤5例,采用颅通定与心律平联合治疗,均获成功,现报道如下。 一、临床资料 (一)一般资料 男3例,女2例;年龄15～73岁(平均34.6岁);预激伴房颤病史2～32年(平均9.4年);平均心室率为123～288(220±46)次/分;转复时间40分钟～4小时;未发现器质性心脏病4例,冠心病1例。以往均无自行终止发作史。 (二)治疗及观察方法 5例入院后,均未用其它抗心律失常药。全部病例采用颅通定针剂(泰安制药厂生产)稀释后缓注,剂量1～1.5mg/kg·次;若无效,则给予心律平注射液(广州明兴药厂生产)稀释后缓注,
From 1989 to 1993, our hospital received a total of 5 cases of WPW syndrome (pre-excitation) with atrial fibrillation. Both craniofacial and heart rhythm combined treatment were successful, are reported below. First, the clinical data (a) General Information 3 males and 2 females; aged 15 to 73 years (mean 34.6 years); preexcited with atrial fibrillation history of 2 to 32 years (average 9.4 years); average ventricular rate of 123 ~ 288 (220 ± 46) beats / min; recovery time 40 minutes to 4 hours; no organic heart disease in 4 cases, 1 case of coronary heart disease. In the past there is no history of termination of seizures. (B) of the treatment and observation of 5 cases were admitted to the hospital, were not used other anti-arrhythmic drugs. All patients were treated with craniotome injection (manufactured by Tai’an Pharmaceutical Factory) diluted at a dose of 1 ~ 1.5mg / kg · once; if not, then given dilute after heart rate injection (Guangzhou Ming Hing Pharmaceutical Factory)